The Board of Directors of Rain Oncology Inc. approved Dr. Richard Bryce transition from his role as the Company's Executive Vice President, Chief Medical Officer to an advisory position with the Company, effective June 1, 2023. Dr. Robert Doebele, the Company's Cofounder, President and Chief Scientific Officer, succeeded Dr. Bryce as the Company's Chief Medical Officer as of such date. In addition, in connection with, and subsequent to the approval of, the Plan, the Company and Nelson Cabatuan agreed that he would transition from his role as the Company's Senior Vice President, Finance and Operations to an advisory position with the Company, effective June 1, 2023.

In connection with the foregoing, Joy Bruce, the Company's Director of Accounting, assumed the role of the Company's principal financial and accounting officer, effective as of such date. Joy Bruce, age 44, has served as the Company's Director of Accounting since January 2022. Previously, she served as the Company's Associate Director of Accounting from December 2020 to December 2021.

Prior to joining the Company, she served as Manager of SEC Reporting at Rigel Pharmaceuticals Inc., from June 2019 to November 2020, where she was responsible for accounting and finance, SEC reporting, financial planning and analysis, research and development and internal control processes and operations. From November 2017 to May 2019, she served as Senior Financial Analyst at Funding Circle, a commercial lender. Ms. Bruce graduated with a B.S. in Business Administration and Accountancy from the University of the Philippines and holds professional certifications as a Certified Public Accountant (Philippines).